These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24807499)

  • 1. Editorial comment from Dr. Yoshimura to potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
    Yoshimura N
    Int J Urol; 2014 Apr; 21 Suppl 1():56. PubMed ID: 24807499
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment from professor Dinis to Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
    Oliveira PD
    Int J Urol; 2014 Apr; 21 Suppl 1():56. PubMed ID: 24807498
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
    Jhang JF; Jiang YH; Kuo HC
    Int J Urol; 2014 Apr; 21 Suppl 1():49-55. PubMed ID: 24807497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial comment from Dr. Yoshimura to Interstitial cystitis is bladder pain syndrome with Hunner's lesion.
    Yoshimura N
    Int J Urol; 2014 Apr; 21 Suppl 1():83-4. PubMed ID: 24807509
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.
    Chiu B; Tai HC; Chung SD; Birder LA
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment from Dr. Hanno to Interstitial cystitis is bladder pain syndrome with Hunner's lesion.
    Hanno P
    Int J Urol; 2014 Apr; 21 Suppl 1():82-3. PubMed ID: 24807508
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment from Dr. Ueda to Assessments of bladder pain syndrome/interstitial cystitis treatment in future trials.
    Ueda T
    Int J Urol; 2014 Apr; 21 Suppl 1():84. PubMed ID: 24807510
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial Comment from Dr Homma to Intravesical tacrolimus in treatment of intractable bladder pain syndrome/interstitial cystitis-a pilot study.
    Homma Y
    Int J Urol; 2019 Jun; 26 Suppl 1():72. PubMed ID: 31144738
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies.
    Wang J; Wang Q; Wu Q; Chen Y; Wu P
    Med Sci Monit; 2016 Sep; 22():3257-67. PubMed ID: 27624897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin injection for lower urinary tract dysfunction.
    Kuo YC; Kuo HC
    Int J Urol; 2013 Jan; 20(1):40-55. PubMed ID: 22571329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can we improve the diagnosis and management of bladder pain syndrome? Part 2:ICI-RS 2018.
    Khullar V; Digesu GA; Veit-Rubin N; Sahai A; Rahnama'i MS; Tarcan T; Chermansky C; Dmochowski R
    Neurourol Urodyn; 2019 Dec; 38 Suppl 5():S71-S81. PubMed ID: 31821630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
    Dellis A; Papatsoris AG
    Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial Comment to Minimally invasive device for intravesical instillation by urological syringe adapter (MID-ii U.S.A.) for catheter-free instillation therapy of the bladder in interstitial cystitis/bladder pain syndrome.
    Meijlink J
    Int J Urol; 2019 Jun; 26 Suppl 1():60. PubMed ID: 31144752
    [No Abstract]   [Full Text] [Related]  

  • 15. Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction.
    Kuo HC
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32545870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial Comment from Dr Yoshimura to Pathophysiology of interstitial cystitis.
    Yoshimura N
    Int J Urol; 2019 Jun; 26 Suppl 1():15. PubMed ID: 31144754
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment from Dr. Hanno to hypersensitive bladder: a solution to confused terminology and ignorance concerning interstitial cystitis.
    Hanno P
    Int J Urol; 2014 Apr; 21 Suppl 1():48. PubMed ID: 24807496
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment from Dr. Nordling to hypersensitive bladder: a solution to confused terminology and ignorance concerning interstitial cystitis.
    Nordling J
    Int J Urol; 2014 Apr; 21 Suppl 1():48. PubMed ID: 24807495
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature.
    Moore DC; Cohn JA; Dmochowski RR
    Toxins (Basel); 2016 Mar; 8(4):88. PubMed ID: 27023601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis.
    Pinto R; Lopes T; Frias B; Silva A; Silva JA; Silva CM; Cruz C; Cruz F; Dinis P
    Eur Urol; 2010 Sep; 58(3):360-5. PubMed ID: 20227820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.